Followers | 13 |
Posts | 1544 |
Boards Moderated | 0 |
Alias Born | 06/14/2018 |
![](https://investorshub.advfn.com/uicon/676580.png?cb=1690354813)
Tuesday, July 11, 2023 7:30:33 PM
On 7-11 you said: "Of course you left out where I said with just eight million shares outstanding the stock will run wild up and down, and that if it's at all legitimate the market cap quickly needs to get to $100mn for a cash raise."
Yes, I left out the first part "with just eight million shares outstanding the stock will run wild up and down" as that is basic common sense understood by everybody which is why about a year ago I explained that the reverse split "in itself" does not lose investors any money as you will own 1/10th the shares but they will be worth 10 times as much so moneywise it is a wash.
I ALSO pointed out that an added benefit to only having 8 million shares outstanding instead of 80 million will be a good thing if in the future we get good news because the having 10 times less shares means those less amount of shares will move up Much More Quicker on any good news because of the 10 times lower float.
NOW, to the second part of your 7-11 post: "if it's at all legitimate the market cap quickly needs to get to $100mn for a cash raise."
That is NOT necessarily true as we know they now have enough cash to last until the end of 2025 and also have agreements and access to more cash if they need it.
NOW, if the share price goes to, let's say $20 and they decide to raise cash at a $16 valuation because they think they can put that cash to good use, ie: additional trials or R+D or whatever, then so be it, LET THEM. A decrease to $16 from $20 is still much better than the below $1 we were at very recently.
NEXT, your post that you referenced was from 6-23 where you said "there's just 8mn shares outstanding so the share price will run wild. Have to wonder why they'd leave themselves with such a low number of outstanding with no immediate large cash raise to up the count?? Hmm. It's a retail day traders stock now. Let's hope the "Review" (already late) doesn't include a move to the OTC."
Part 2 of your 6-23 post: "Have to wonder why they'd leave themselves with such a low number of outstanding with no immediate large cash raise to up the count?? Hmm."
You may have to wonder that but to everyone else it is obvious. They were left with a low number of shares because they DID A REVERSE SPLIT. You see, that's what happens with a RS, you LOWER your number of shares. DUH!
Part 3 of your 6-23 post: " It's a retail day traders stock now." FALSE. Day traders by definition are very short term traders, hence the word DAY. The retail or institutional buyers who have brought the price from below $1 to above $5 seem be to longer term holders, not day traders.
Part 4 of your 6-23 post: "Let's hope the "Review" (already late) doesn't include a move to the OTC."
Already assessed as an totally assinine statement.
Recent MRKR News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:05:47 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 10:25:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:40:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:21 PM
- Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies • GlobeNewswire Inc. • 04/08/2024 11:00:39 AM
- Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results • GlobeNewswire Inc. • 03/25/2024 09:45:00 PM
- Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference • GlobeNewswire Inc. • 03/22/2024 04:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:58:51 PM
- Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601 • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:30:48 PM
- Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization • GlobeNewswire Inc. • 01/08/2024 01:24:49 PM
- Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024” • GlobeNewswire Inc. • 12/21/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:35:22 PM
- Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse • GlobeNewswire Inc. • 12/11/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:37:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:03:53 PM
- Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 11:10:46 AM
- Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse • GlobeNewswire Inc. • 09/11/2023 11:00:00 AM
- Marker Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 08/30/2023 12:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:37:04 PM
- Marker Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2023 08:30:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:03:55 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM